Introduction {#s1}
============

Depression is a leading psychiatric illness, with high morbidity and mortality ([@CIT0047]). The lack of appropriate, rapidly acting antidepressants is probably due to the direct pathomechanism of depression being unknown, and this leads to the high suicide statistics. Approximately 50% of those diagnosed with major depressive disorder do not respond to antidepressants when using them for the first time ([@CIT0008]). Long-term antidepressant treatment generates many side effects, and more than 30% of depressed patients do not experience any mood improvement at all ([@CIT0007]). Until now, only one drug, ketamine, has shown rapid action even in treatment-resistant patients ([@CIT0022]; [@CIT0018]; [@CIT0011]). One drug, ketamine, has shown rapid and sustained action even in treatment-resistant patients ([@CIT0022]; [@CIT0018]. This indicates promise for modulators of the glutamatergic system, which may lead to the establishment of homeostasis between glutamate and GABA in the central nervous system (CNS) ([@CIT0039]; [@CIT0040]; [@CIT0020]; [@CIT0032]; [@CIT0033]). In addition, some trace elements, such as magnesium and zinc, are involved in glutamatergic attenuation through their binding sites at the N-methyl-d-aspartate (NMDA) receptor ([@CIT0042]). Preclinical findings indicate that zinc deficiency has been shown to produce depressive-like behavior ([@CIT0037]; [@CIT0046]; [@CIT0045]; [@CIT0049]; [@CIT0029]; [@CIT0025], [@CIT0026], [@CIT0027]). Clinical studies indicate that zinc is lower in the blood of depressed people ([@CIT0042]), and that zinc supplementation may produce antidepressant effects alone and in combination with conventional antidepressant therapies ([@CIT0036]; [@CIT0038] [@CIT0041]..

Zinc is an important trace element in the central nervous system and seems to be involved in neurotransmission. As a natural ligand, it was found to activate the metabotropic GPR39 receptor ([@CIT0006]). Highest levels of GPR39 are found in the brain regions involved in emotion, such as the amygdala and hippocampus ([@CIT0023]; [@CIT0017]). The GPR39 signals with high constitutive activity via G~q~, which stimulates transcription mediated by the cyclic adenosine monophosphate (cAMP) following inositol 1,4,5-triphosphate turnover, as well as via G~12/13~, leading to activation of transcription mediated by the serum response element ([@CIT0013]). Zinc was found to be a ligand capable of stimulating the activity of the GPR39, which activates the G~q~, G~12/13~, and G~s~ pathways ([@CIT0006]). Since zinc shows antidepressant properties and its deficiency leads to the development of depression-like and anxiety-like behaviors ([@CIT0049]; [@CIT0041], we investigated whether the GPR39 receptor may be involved in the pathophysiology of depression. Recently, we found GPR39 down-regulation in the frontal cortex and hippocampus of zinc-deficient rodents and suicide victims ([@CIT0028]). On the other hand, we observed up-regulation of the GPR39 after chronic antidepressant treatment ([@CIT0030]). In the present study, we investigated behavior in mice lacking a GPR39 as well as an hypothalamus-pituitary-adrenal axis (HPA) axis and proteins such as CREB, BDNF, and TrkB, all of which are important in the pathophysiology of depression and the antidepressant response.

Methods {#s2}
=======

Animals {#s3}
-------

All of the procedures were conducted according to the National Institute of Health Animal Care and Use Committee guidelines, which were approved by the Ethical Committee of the Jagiellonian University Collegium Medicum, Kraków.

CD-1 male mice (\~22g) were housed with a natural day-night cycle, a temperature of 22±2°C and humidity at 55±5%. The mice received a zinc-adequate (33.5mg Zn/kg) or zinc-deficient (0.2mg Zn/kg) diet purchased from MP Biomedicals (France) and administered for 6 weeks. The access to food as well as water was ad libitum.

GPR39 (−/−) male mice as described by [@CIT0015] were generated through homologous recombination by Deltagen, Inc. by targeting the first exon of GPR39 and replacing the nucleotides from position 278 to 647 of the open reading frame with a neomycin-containing cassette. The chimeric males were crossed with C57BL/6 females and then backcrossed into C57BL/6 mice. The mice were obtained through heterozygous breeding, resulting in wild-type (WT), homozygous, or heterozygous littermates. Genotypes were verified by polymerase chain reaction. Specific primers for the WT and one specific primer for the insert sequences were used.

As with the CD-1 mice, the GPR39 knockouts (KOs) were housed under standard laboratory conditions. GPR39 KO (−/−) and GPR39 WT (+/+) mice received only a standard diet with appropriate zinc amounts.

Forced Swim Test {#s4}
----------------

The forced swim test (FST) was carried out on GPR39 KO and WT mice. In the classical test described by [@CIT0035], mice were dropped individually into a glass cylinder containing water. The total duration of immobility after adaptation time (the first 2 minutes) was measured during the following 4 minutes of the test.

The immobility time in the FST reflects the level of despair of the mice, prolonged immobility suggesting depressive-like behavior. Because [@CIT0035] described FST as being a means of evaluating potential antidepressant properties of drugs, we prolonged the test, as described by Młyniec et al. (2014b), from 4 to 6 minutes, during which time the duration of immobility was measured.

Tail Suspension Test {#s5}
--------------------

WT and GPR39 KO mice were subjected to the tail suspension test (TST) previously described by Mlyniec and Nowak (2012). Animals were fastened with medical adhesive tape by the tail 30cm below a flat surface and suspended for 6 minutes. During this period, the total immobility time was measured. Immobility time (when mice hung passively without limb movement) was scored manually.

Locomotor Activity {#s6}
------------------

Locomotor activity was measured by photoresistor actometers. The number of times the light beams were crossed by GPR39 or WT mice was counted by placing them individually in an actometer, with the test duration being between 2 and 8 minutes.

Light/Dark Test {#s7}
---------------

WT and GPR39 KO mice were subjected to the light/dark test as previously described by [@CIT0049]. The fully automated light/dark box apparatus (Stoelting) consisted of white and black compartments, which were connected by a small opening located in the center of the common partition. Mice were individually placed in the apparatus for 10 minutes and allowed to freely explore. The following parameters were quantified in the test: 1) time spent in lit compartment (seconds), 2) entries into the lit compartment (number), 3) line crossing (number), 4) immobility time (seconds), 5) freezing (seconds), and 6) overall distance travelled (meters).

Zinc Concentration {#s8}
------------------

The serum zinc concentration in both GPR39 KO and WT mice was measured by total reflection X-ray fluorescence as described by Młyniec et al. (2014b). This method is based on the same physical principles as energy dispersive X-ray fluorescence. Galium was added to the serum sample as an internal standard (20mL) to achieve the final concentration of 5mg/L. For all measurements, the total reflection X-ray fluorescence spectrometer Nanohunter (Rigaku) was used as well as a single measurement time of 2000 seconds and a Mo X-ray tube (50kV, 0.8 mA). The detection limits for Zn were about 0.4mg/L.

Corticosterone Assay {#s9}
--------------------

The serum corticosterone concentration was determined by a radioimmunological method as described by Młyniec et al. (2013a). Corticosterone was extracted from the serum by ethanol. This extract (ethanol-serum) was dried under a nitrogen stream and then dissolved in 0.1mL of 0.05mM phosphate buffer. Extracts were incubated with a 0.1-mL solution of 1,2,6,7-\[3H\]-corticosterone and with a 0.1-mL solution of a corticosterone antibody (Chemicon) for 16 hours at 4°C. Bound and free corticosterone were separated using dextran-coated charcoal. Incubation time for the samples was established for 10 minutes at 4°C with 0.2mL of 0.05% dextran and 0.5% charcoal suspension. After centrifugation, the supernatant was placed in a scintillator. The radioactivity was measured in a counter (Beckmann LS 335). The corticosterone content was calculated using a log-logit transformation.

Western-Blot Analysis {#s10}
---------------------

Glucocorticoid receptor (GR) levels were determined in the frontal cortex and hippocampus of zinc-adequate and -deficient mice after administration of the diet for 6 weeks. In the GPR39 KO and WT mice, in addition to GR, the levels of such proteins as CREB, BDNF, and TrkB were also determined, as described by Młyniec et al. (2014b). All mice were previously subjected to the FST. After rapid decapitation of the mice (24 hours after FST procedure), tissues were immediately isolated on dry ice and then frozen at −80°C until analysis took place.

The frontal cortex and hippocampus were homogenized in 2% sodium dodecyl sulphate. After centrifugation, the total amount of protein was determined in the supernatant (BCA Protein Assay Kit, Pierce Biotechnology). The samples were separated using sodium dodecyl sulphate-polyacrylamide gel electrophoresis (Bio-Rad) under a constant voltage and then transferred (in a semi-dry transfer process) to nitrocellulose membranes. To avoid nonspecific binding, membranes were blocked for 60 minutes at room temperature with blocking solution (Roche). Then the membranes were incubated overnight at 4°C with primary antibodies: anti-GR (1/1000, Santa Cruz Biotechnology), anti-CREB (1/1000), anti-BDNF (1/1000), and anti-TrkB (1/400) (Abcam, Cambridge, UK). After washing (3×10 minutes in Tris-buffered saline with Tween 20), the membranes were incubated in a secondary antibody with a horseradish peroxidase-conjugated anti-mouse or anti-rabbit immunoglobulin G (Western Blotting Kit, Roche) for 60 minutes at room temperature. Blots were developed using an enhanced chemiluminescence reaction (BM Chemiluminescence Western Blotting Kit, Roche). The GR, CREB, BDNF, and TrkB signals were visualized and quantified with the Gel Doc XR+ system and Image Lab 4.1 software (both Bio-Rad). To confirm equal loading of the samples on the gel, the membranes were incubated with a loading control antibody and then processed as described above. The density of each GR, CREB, BDNF, or TrkB protein band was normalized to the density of the loading control band.

Statistical Analysis {#s11}
--------------------

The data are presented as the mean±SEM and were evaluated with the Student *t* test using GraphPad Prism software (San Diego, CA). *P*\<.05 was considered to be statistically significant.

Results {#s12}
=======

Behavioral Studies of Gpr39 KO Mice {#s13}
-----------------------------------

Before experiments, mice were weighed. There were no differences between WT and GPR39 KO groups \[*t*(10)=0.2715, *P*=.7916\].

The effect of deletion of the GPR39 on immobility time in the FST is shown in [Figure 1A](#F1){ref-type="fig"}. GPR39 KO mice showed an increased immobility time in the FST designed by [@CIT0035] in comparison with WT mice \[*t*(15)=2.563, *P*=.0217\]. We found a more significant increase in immobility time in GPR39 KO vs WT using a modified FST ([@CIT0028]) \[*t*(15)=4.571, *P*=.0004\] ([Figure 1B](#F1){ref-type="fig"}). We also found an increased immobility time in the TST in GPR39 KO mice \[*t*(10)=2.415, *P*=.0363\] ([Figure 2](#F2){ref-type="fig"}).

![The effect of GPR39 knockout (KO) on immobility time in the standard (A) and prolonged (B) forced swim test in GPR39 KO mice. Values are the means ± SEM of 6 to 7 animals per group. \* p \< 0.05, \*\* p \< 0.001 vs wild-type control.](ijnppy_pyu002_f0001){#F1}

![The effect of GPR39 knockout (KO) on immobility time in the tail suspension test in GPR39 KO mice. Values are the means ± SEM of 6 animals per group. p\* \< 0.05 vs wild-type control.](ijnppy_pyu002_f0002){#F2}

There were no differences in locomotor activity between GPR39 KO and WT mice after 2 \[*t*(15)=0.004016, *P*=.9968\], 4 \[*t*(15)=0.1016, *P*=.9205\], 6 \[*t*(15)=.04298, *P*=.9663\], and 8 \[*t*(15)=0.05586, *P*=.9562\] minutes ([Table 1](#T1){ref-type="table"}).

###### 

The Effect of GPR39 KO on Spontaneous Locomotor Activity in GPR39 KO Mice. Values are the means ± SEM of 6 to 7 animals per group.

             2 min         4 min         6 min         8 min
  ---------- ------------- ------------- ------------- -------------
  WT         158.1±15.08   307.8±24.42   458.5±29.09   609.3±35.23
  GPR39 KO   158.2±18.45   311.9±31.65   456.5±39.81   605.9±47.21

In the light/dark box test, GPR39 KO mice displayed decreased entries into the lit compartment, line crossing, and enhanced immobility time compared with WT control mice ([Table 2](#T2){ref-type="table"}).

###### 

Behavioral Parameters Quantified in the Light/Dark Test in WT and GPR 39 KO mice. Values are the means ± SEM of 6 animals per group. \*p \< 0.05, \*\*p \< 0.01 vs proper control.

                                              *Wild type*   *GPR39 knockout*   *Statistics*
  ------------------------------------------- ------------- ------------------ -----------------------------------
  Time spent in lit compartment (s)           300.5±30.47   249.0±26.24        \[*t*(10) = 1.281, *p* = 0.2291\]
  Entries into the lit compartment (number)   18.67±1.978   13.17±0.543 \*     \[*t*(10) = 2.628, *p* = 0.0230\]
  Line crossing (number)                      41.17±2.713   25.67±1.116 \*\*   \[*t*(10) = 5.284, *p* = 0.0004\]
  Immobility time (s)                         103.5±15.86   146.9±10.42 \*     \[*t*(10) = 2.287, *p* = 0.0452\]
  Freezing (s)                                128.0±12.95   164.3±11.03        \[*t*(10) = 2.130, *p* = 0.0590\]
  Overall distance travelled (m)              23.75±2.049   23.42±1.540        \[*t*(10) = 0.131, *p* = 0.8982\]

Serum Zinc Concentration in GPR39 KO Mice {#s14}
-----------------------------------------

There was no difference between GPR39 KO (1.707±0.1606mg/L) and WT mice (1.848±0.1130mg/L) in terms of serum zinc concentration \[*t*(11)=0.7328, *P*=.4790\].

CREB, BDNF, and TrkB Protein Levels in GPR39 KO Mice {#s15}
----------------------------------------------------

The effect of deletion of the GPR39 on CREB, BDNF, and TrkB levels in mice is shown in [Figure 3](#F3){ref-type="fig"}. GPR39 KO mice show reduced CREB levels in the hippocampus \[*t*(12)=2.427, *P*=.0319\] but not in the frontal cortex \[*t*(12)=0.8192, *P*=.4286\] in comparison with WT mice ([Figures 3A](#F3){ref-type="fig"} and [D](#F3){ref-type="fig"}, respectively).

![The effect of GPR39 knockout (KO) on CREB, BDNF, and TrkB levels in the hippocampus (A, B, and C, respectively) and in the frontal cortex (D, E, and F, respectively) of GPR39 KO mice. Values are the means ± SEM of 6 to 7 animals per group. \*p \< 0.05 vs wild-type control.](ijnppy_pyu002_f0003){#F3}

In a similar way to the CREB levels, GPR39 KO mice also have reduced BDNF levels in the hippocampus \[*t*(10)=2.510, *P*=.0309\] ([Figure 3B](#F3){ref-type="fig"}), but not in the frontal cortex, in comparison with WT control mice \[*t*(12)=0.6015, *P*=.5587\] ([Figure 3E](#F3){ref-type="fig"}). There was no difference in TrkB levels between GPR39 KO and WT mice in the hippocampus \[*t*(12)=0.6861, *P*=.5057\] or frontal cortex \[*t*(12)=0.9219, *P*=.3747\] ([Figure 3C](#F3){ref-type="fig"} and [F](#F3){ref-type="fig"}, respectively).

Serum Corticosterone Concentration in Zinc-Deficient and GPR39 KO Mice {#s16}
----------------------------------------------------------------------

The effects of zinc deficiency on the serum corticosterone level are shown in [Figure 4A](#F4){ref-type="fig"}. A 6-week zinc-deficient diet causes a significant increase in serum corticosterone concentration in comparison with control mice \[*t*(8)=2.547, *P*=.0343\]. There were no significant differences between GPR39 KO and WT \[*t*(9)=1.298, *P*=.2266\] ([Figure 4B](#F4){ref-type="fig"}).

![The effect of a zinc-deficient diet (A) or GPR39 knockout (B) on serum corticosterone level in mice. Values are the means ± SEM of 6 to 7 animals per group. \*p \< 0.05 vs proper control.](ijnppy_pyu002_f0004){#F4}

GR Protein Levels in Zinc-Deficient and GPR39 KO Mice {#s17}
-----------------------------------------------------

Administration of a zinc-deficient diet for 6 weeks causes a reduction in glucocorticoid receptor levels in the hippocampus \[*t*(11)=2.649, *P*=.0226\] and frontal cortex \[*t*(12)=2.475, *P*=.0292\] ([Figure 5A](#F5){ref-type="fig"} and [B](#F5){ref-type="fig"}, respectively). There were no changes in the GR levels in the hippocampus \[*t*(12)=0.3628, *P*=.7231\] or the frontal cortex \[*t*(12)=0.4638, *P*=.6511\] of GPR39 KO mice in comparison with WT control mice ([Figure 5C](#F5){ref-type="fig"} and [D](#F5){ref-type="fig"}, respectively).

![The effect of a zinc-deficient diet (A,B) or GPR39 knockout (C,D) on glucocorticoid receptor levels in the hippocampus (A,C) and frontal cortex (B,D) of mice. Values are the means ± SEM of 6 to 7 animals per group. \* *p* \< 0.05 vs. proper control.](ijnppy_pyu002_f0005){#F5}

Discussion {#s18}
==========

In the present study, we found that elimination of GPR39 leads to the development of depressive-like behavior, as measured by the FST and TST. Additionally, we found decreased entries into the lit compartment and line crossing and increased immobility time in the light/dark test, indicating anxiety-like phenotype in GPR 39 KO mice. Although not statistically significant, we also observed some tendencies towards less time spent in the lit compartment (decreased by 17%) and increased and freezing behavior (28%) in GPR39 KO compared to WT mice.

The GPR39 was found to be activated by zinc ions ([@CIT0006]; [@CIT0050]), and the link between zinc and depression is well known ([@CIT0019], [@CIT0020]; [@CIT0043]; [@CIT0041], [@CIT0042]). [@CIT0016] did not find behavioral abnormalities in the FST after administering antisense of DNA for GPR39-1b. In our present study, mice with general GPR39 KO were used. GPR39-1a full-length isoform was found to be a receptor for zinc ions, whereas GPR39-1b, corresponding to the 5-transmembrane truncated form ([@CIT0006]), did not respond to zinc stimulation, which means that the GPR39-1b splice variant is not a receptor of Zn^2+^ ([@CIT0051]).

Activation of the GPR39 triggers diverse neuronal pathways ([@CIT0013], [@CIT0014]; [@CIT0034]) that may be involved in neuroprotection ([@CIT0004]). Zinc stimulates GPR39 activity, which activates the Gα~s~, Gα~q~, and Gα~12/13~ pathways ([@CIT0006]). The Gα~q~ pathway triggers diverse downstream kinases and mediates CREB activation and cyclic adenosine monophosphate response element-dependent transcription. Our previous study showed decreased CREB, BDNF, and TrkB proteins in the hippocampus of mice under zinc-deficient conditions ([@CIT0028]). Moreover, disruption of the CaM/CaMKII/CREB signaling pathway was found after administration of a zinc-deficient diet for 5 weeks ([@CIT0010]). Since GPR39 was discovered to be a receptor for zinc, we previously investigated whether GPR39 may be involved in the pathophysiology of depression and suicide behavior. In our postmortem study, we found GPR39 down-regulation in the hippocampus and the frontal cortex of suicide victims ([@CIT0028]). In the present study, we investigated whether GPR39 KO would decrease levels of such proteins as CREB, BDNF, and TrkB, which were also found to be impaired in depression in suicide victims ([@CIT0005]; [@CIT0031]). Indeed, we found that lack of the GPR39 gene causes CREB and BDNF reduction in the hippocampus, but not in the frontal cortex, suggesting that the hippocampus might be a specific region for CREB and BDNF down-regulation in the absence of a zinc receptor. The CA3 region of the hippocampus seems to be strongly involved in zinc neurotransmission. [@CIT0001] found that the GPR39 is activated by synaptically released zinc ions in the CA3 area of the hippocampus. This activation triggers Ca^2+^ and Ca^2+^/calmodulin kinase II, suggesting that it has a role in neuron survival/neuroplasticity in this brain area ([@CIT0001]), which is of importance in antidepressant action. In this study, we did not find any changes in TrkB levels in either the hippocampus or frontal cortex; in the case of the hippocampus, this may be a compensatory mechanism, and it needs further investigation.

There is strong evidence that zinc deficiency leads to hyperactivation of the HPA axis ([@CIT0048]; [@CIT0044]; [@CIT0024], [@CIT0030]), which is activated as a reaction to stress. The activity of the HPA axis is regulated by negative feedback through GR receptors that are present in the brain, mainly in the hippocampus ([@CIT0012]). This mechanism was shown to be impaired in mood disorders. In the present study, we compared corticosterone and GR receptor levels in zinc-deficient and GPR39 KOs. We found an elevated corticosterone concentration in the serum and decreased GR levels in the hippocampus and frontal cortex of mice receiving a zinc-deficient diet. However, there were no changes in corticosterone or GR levels in GPR39 KO mice in comparison with WT mice. This suggests that the depressive-like behavior observed in mice lacking the GPR39 gene is not due to higher corticosterone concentrations and that there is no link between GPR39 and the HPA axis. In the present study, we did not find any changes in the serum zinc level in GPR39 KO mice in comparison with WT mice, which indicates a possible correlation between serum zinc and serum corticosterone.

Depressive-like changes with component of anxiety observed in GPR39 KO mice may result of glutamatergic abnormalities that were found in cases of zinc deficiency, but this requires further investigation. Zinc as an NMDA antagonist modulates the glutamatergic system, which is overexcited during depression. Zinc co-released with glutamate from "gluzinergic" neurons modulates excitability of the brain by attenuating glutamate release ([@CIT0009]). The GPR39 zinc receptor seems to be involved in the mechanism regulating the amount of glutamate in the brain ([@CIT0001]). Activation of the GPR39 up-regulates KCC2 and thereby enhances Cl^−^ efflux in the postsynaptic neurons, which may potentiate γ-aminobutyric acid~A~-mediated inhibition ([@CIT0003]).

Our present study shows that deletion of GPR39 leads to depressive-like behaviors in animals, which may be relevant to depressive disorders in humans. Decreased levels of CREB and BDNF proteins in the hippocampus of GPR39 KO mice support the involvement of GPR39 in the synthesis of CREB and BDNF, proteins that are important in neuronal plasticity and the antidepressant response.
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